Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
As a novel inhibitor of nicotinamide N-methyltransferase (NNMT), 5-amino-1mq has shown broad application prospects in anti-aging studies
There may be instances where certain conditions, such as poor nutrition, intestinal issues, infections, and cancer, may lead to B12 deficiency
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
Healthcare professionals who encounter patients using unlicensed peptides should approach the conversation without judgement, document use carefully, and consider appropriate baseline investigations including liver function tests, lipid profile, and renal function
US$ 20.11
US$ 23.87
US$ 23.96
US$ 27.06
US$ 28.06
US$ 28.39
US$ 24.86
US$ 24.70
US$ 25.12
